CVS Health Corp

Most Recent

  • uploads///Walgreens
    Earnings Report

    Will Walgreens’ Q3 Results Beat Wall Street’s Forecast?

    Unlike several other US companies, Walgreens didn’t suspend its dividends due to COVID-19. As of July 6, the company’s dividend yield was 4.2%.

    By Sirisha Bhogaraju
  • uploads///walmart upcoming earnings
    Consumer

    Walmart to Boost Pharmacy Business with CareZone’s Tech Acquisition

    Today, CNBC reported that Walmart (NYSE:WMT) has acquired prescription management technology from CareZone to boost its pharmacy space.

    By Rajiv Nanjapla
  • uploads///walgreens coronavirus
    Consumer

    Why Walgreens Stock Fell despite Upbeat Q2 Earnings

    Walgreens Boots Alliance (NASDAQ:WBA) reported strong earnings for the second quarter of fiscal 2020. The second quarter ended on February 29.

    By Sirisha Bhogaraju
  • uploads///walgreens upcoming earnings
    Consumer

    What to Expect from Walgreens’ Q2 Earnings

    Analysts expect Walgreen’s second-quarter sales to rise 2.1% YoY to $35.3 billion. The company is scheduled to release its earnings results on April 2.

    By Sirisha Bhogaraju
  • uploads///AdobeStock__Editorial_Use_Only
    Consumer

    Bears Return to Walgreens Stock, Challenges Persist

    Walgreens Boots Alliance stock is feeling pressure again. The stock fell about 6% on Wednesday, which reflects its weaker start to fiscal 2020.

    By Amit Singh
  • uploads///AdobeStock__Editorial_Use_Only
    Earnings Report

    Walgreens Posts Disappointing Q1 Earnings Results

    Today, Walgreens Boots Alliance reported lower-than-expected results for the first quarter of fiscal 2020. The adjusted EPS fell on a YoY basis.

    By Amit Singh
  • uploads///ACB
    Cannabis

    Can the US Cannabis Market Rescue ACB?

    Aurora Cannabis (ACB) stock isn’t in the best shape today. As reported by BNN Bloomberg, the company’s CEO, Terry Booth, is justifiably worried.

    By Margaret Patrick
  • uploads///AdobeStock__Editorial_Use_Only
    Consumer

    CVS Health Stock: What’s Fueling Growth and Will the Uptrend Last?

    CVS Health stock is up about 13% in November. Strong financial performance is driving the stock higher, but low earnings growth could limit further upside.

    By Amit Singh
  • uploads///stock picture HJHQsQohM
    Consumer

    Wellington Management: Analyzing Its Top Holdings

    Wellington Management filed its 13F on Wednesday. Based on the filing, the market value of total publicly traded securities was around $443.45 billion.

    By Rabindra Samanta
  • uploads///Walgreens
    Company & Industry Overviews

    Walgreens: Reports of KKR Buyout Offer, Stock Rose

    Walgreens Boots Alliance (WBA) stock rose 5.1% on Monday. Bloomberg reported that private equity firm KKR has formally offered to buy the company.

    By Sirisha Bhogaraju
  • uploads///AdobeStock__Editorial_Use_Only
    Consumer

    CVS Keeps Beating Estimates, Raises Earnings Outlook

    CVS Health (CVS) again beat analysts’ revenue and EPS estimates when it released its Q3 earnings today. Its stock was up about 3% in premarket trading.

    By Amit Singh
  • uploads///AdobeStock__Editorial_Use_Only
    Company & Industry Overviews

    Why Walgreens Is Mulling Over Going Private

    Reuters reports that Walgreens Boots Alliance (WBA) is exploring options to go private and has engaged Evercore Partners to put together a deal.

    By Amit Singh
  • uploads///AdobeStock__Editorial_Use_Only
    Consumer

    Why CVS Stock Looks Strong Ahead of Q3 Earnings

    CVS Health (CVS) is slated to announce its third-quarter earnings results tomorrow. We believe the company sustained its sales momentum in the quarter.

    By Amit Singh
  • uploads///AdobeStock__Editorial_Use_Only
    Consumer

    Walgreens Stock: Q4 Beat Might Not Spur Recovery

    Walgreens Boots Alliance (WBA) struggled in fiscal 2019. Sales headwinds and pressure on margins from reimbursements dragged the stock down.

    By Amit Singh
  • uploads///AdobeStock__Editorial_Use_Only
    Consumer

    Walgreens Stock: What to Expect from Its Q4 Earnings

    Walgreens is scheduled to report its fourth-quarter earnings before the markets open on October 28. We expected a limited downside in Walgreens stock.

    By Amit Singh
  • uploads///Walgreens stock
    Consumer

    Walgreens Stock Fizzles after Brief Recovery

    Pressure on Walgreens (WBA) stock had started easing a bit. However, the revival was short lived, and WBA fell about 2% last week.

    By Amit Singh
  • uploads///Walgreens stock
    Company & Industry Overviews

    Walgreens Stock: Deutsche Bank Recommends a ‘Sell’

    Deutsche Bank started coverage on Walgreens stock with a “sell” recommendation. The stock closed 4.3% lower on Thursday after the news.

    By Amit Singh
  • uploads///CVS Walgreens
    Consumer

    Why Walgreens Stock Underperformed CVS in August

    Walgreens Boots Alliance (WBA) stock underperformed CVS Health (CVS) stock last month, with Walgreens falling 6% and CVS rising about 9%.

    By Amit Singh
  • uploads///Curaleaf
    Cannabis

    Why Has Curaleaf Lost 13.5% in August?

    As of August 17, Curaleaf Holdings (CURA) (CURLF) was trading at 9.00 Canadian dollars—a fall of 13.5% in August.

    By Rajiv Nanjapla
  • uploads///AdobeStock_
    Consumer

    Charlotte’s Web Holdings Stock Down after Earnings

    Charlotte’s Web Holdings stock (CWBHF)(CWEB) was down 6.6% yesterday after the company reported lower-than-expected Q2 earning results.

    By Sushree Mohanty
  • uploads///CVS Walgreens
    Consumer

    Walgreens or CVS Stock: Which Is a Better Value Buy?

    Walgreens and CVS Health shares are trading at a low valuation multiple. The stocks have fallen 22.3% and 8.7%, respectively, in 2019.

    By Amit Singh
  • uploads///CVS Health
    Earnings Report

    CVS Beats Q2 Estimates by a Wide Margin

    CVS Health (CVS) announced better-than-expected second-quarter results on Wednesday. The company sustained the first-quarter momentum.

    By Amit Singh
  • uploads///Walgreens Stores
    Company & Industry Overviews

    Walgreens Will Close 200 US Stores

    In a regulatory filing on Tuesday, Walgreens Boots Alliance (WBA) announced that it will close 200 stores in the US to focus on store optimization.

    By Amit Singh
  • uploads///AMZN
    Consumer

    Amazon Stock: Does the Recent Slide Indicate a Buy?

    Amazon (AMZN) stock has fallen more than 10% since the company reported mixed second-quarter results. The stock fell 3.2% on Monday.

    By Sophia Nicholson
  • uploads///CVS Stock
    Consumer

    Could CVS Health’s Q2 Results Boost Its Stock?

    CVS Health (CVS) is set to announce its second-quarter results on August 7. We expect CVS to sustain its momentum in the quarter, supporting its stock.

    By Amit Singh
  • uploads///Align technolgies
    Company & Industry Overviews

    Align Technology Stock Recovers after Tanking Last Week

    Align Technology stock (ALGN) took a massive hit after Q2 earnings. So what was behind the massive decline, and what’s helping the stock recover?

    By Sushree Mohanty
  • uploads///drugs
    Company & Industry Overviews

    Amazon Suffers a Blow in Talent Row with CVS Health

    Amazon’s (AMZN) efforts to crack the more than $600 billion prescription drug market in the US has suffered a blow, albeit a mild one. A federal judge in Rhode Island ruled on June 18 that a former executive at pharmacy chain CVS Health (CVS) couldn’t work for Amazon’s pharmacy business, PillPack.

    By Ruchi Gupta
  • uploads///simone van der koelen  unsplash
    Healthcare

    CVS Health Stock: Analysts’ Suggestions

    CVS Health’s top line is expected to grow at a healthy double-digit rate in the near term due to the Aetna acquisition.

    By Amit Singh
  • uploads///medications _
    Healthcare

    Is CVS Stock Too Cheap to Ignore?

    CVS Health (CVS) has fallen 18.5% on a YTD (year-to-date) basis as of June 3. CVS Health’s bottom line is expected to fall in the near term.

    By Amit Singh
  • uploads///CVS ANR
    Consumer

    Will Pressure on Earnings Limit the Upside in CVS Health Stock?

    CVS Health (CVS) impressed investors with its first-quarter sales and earnings.

    By Amit Singh
  • uploads///thermometer _
    Consumer

    CVS Health Stock Rises 5.4% on Strong First-Quarter Earnings

    CVS Health (CVS) stock jumped 5.4% on May 1 on stronger-than-expected first-quarter results.

    By Amit Singh
  • uploads///CVS Stock
    Consumer

    How Analysts Rate CVS Stock

    CVS Health (CVS) stock is trading at 7.8x its 2019 estimated EPS of $6.79.

    By Amit Singh
  • uploads///aid _
    Consumer

    What to Expect from CVS Health’s First-Quarter Results

    CVS Health (CVS) plans to announce its first-quarter results on Wednesday, May 1.

    By Amit Singh
  • uploads///CVS ANR
    Consumer

    What Analyst Ratings Indicate for CVS Stock

    Among the 27 analysts covering CVS Health (CVS) stock, 18 analysts suggest a “buy,” and nine analysts recommend a “hold.”

    By Amit Singh
  • uploads///medications _
    Consumer

    Oppenheimer Downgrades CVS Health Stock to ‘Perform’

    On April 15, Oppenheimer downgraded CVS Health (CVS) stock to “perform” from “outperform.”

    By Amit Singh
  • uploads///CVS WBA
    Consumer

    Pharmaceutical Retailers Underperformed Broader Markets

    CVS and Walgreens stock fell 17.7% and 7.4%, respectively, in the first quarter, which reflected the weak earnings outlook.

    By Amit Singh
  • uploads///grocery store _
    Consumer

    Consumer Staples Stocks: Stragglers in Q1

    Despite 10.5% growth in the first quarter, the Consumer Staples Select Sector SPDR ETF (XLP) lagged the benchmark index, which rose 13.1%.

    By Amit Singh
  • uploads///CVS WBA ANR
    Consumer

    What’s the Potential Upside in CVS and WBA Stock?

    Analysts maintain a positive outlook on CVS Health (CVS) stock.

    By Amit Singh
  • uploads///medicine _
    Consumer

    Are CVS and Walgreens Stock Too Cheap to Ignore?

    CVS Health (CVS) is down 19.4% on a YTD basis as of April 3.

    By Amit Singh
  • uploads///WBA
    Consumer

    What Analysts Recommend for Walgreens after Q2

    Most analysts maintain a “hold” rating on Walgreens Boot Alliance (WBA) stock.

    By Amit Singh
  • uploads///WBA EPS
    Consumer

    What Affected Walgreens’s Q2 EPS?

    Walgreens Boots Alliance (WBA) posted adjusted earnings of $1.64 per share, a 5.4% decrease on a YoY basis.

    By Amit Singh
  • uploads///WBA Sales
    Consumer

    Why Walgreens Missed Analysts’ Sales Estimate in Q2

    Walgreens Boots Alliance’s (WBA) second-quarter sales of $34.5 billion increased 4.6% on a YoY basis.

    By Amit Singh
  • uploads///pills _
    Consumer

    Walgreens Stock Fell ~13% on Weak Q2 and Lower Guidance

    Walgreens Boots Alliance (WBA) stock dropped 12.8% on Tuesday, April 2.

    By Amit Singh
  • uploads///WBA Stock
    Consumer

    What’s in the Offing for Walgreens Stock?

    Walgreens Boot Alliance disappointed with weaker-than-expected earnings results for the second quarter of fiscal 2019 on April 2.

    By Amit Singh
  • uploads///health _
    Consumer

    Walgreens’ Weak Q2 Results Weigh on Its Stock

    Walgreens Boots Alliance (WBA) reported dismal results for the second quarter of fiscal 2019 on April 2.

    By Amit Singh
  • uploads///WBA ANR
    Consumer

    Walgreens Stock: Why Analysts Lowered the Target Price

    Analysts lowered their target price on Walgreens Boot Alliance (WBA) stock. On March 27, Cowen lowered its target price to $66 from $75.

    By Amit Singh
  • uploads///
    Company & Industry Overviews

    Amazon Challenges Walgreens and CVS Health Again

    Amazon (AMZN) recently began letting customers use funds in their special healthcare savings account to pay for purchases of eligible products on its marketplace, the company confirmed to CNBC.

    By Ruchi Gupta
  • uploads///Week_
    Healthcare

    What Drove Curaleaf’s Stock Price Last Week?

    On March 22, the US market fell on concerns over global growth prospects as the long-term bond yield fell below the short-term yield.

    By Rajiv Nanjapla
  • uploads///drug _
    Consumer

    Walgreens Stock Continues to Fall Due to Multiple Price Cuts

    Walgreens Boot Alliance (WBA) shares have taken a beating the past few days. Multiple analysts lowered their target price on the stock.

    By Amit Singh
  • uploads///pill _
    Consumer

    Walgreens and CVS Stocks Look Attractive despite Challenges

    Walgreens Boots Alliance (WBA) and CVS Health (CVS) shares have taken a beating. Bottom-line challenges spooked investors.

    By Amit Singh
  • uploads///pills _
    Consumer

    What’s Hurting CVS and Walgreens Stocks?

    Walgreens Boots Alliance stock (WBA) fell 6.4% on March 1 after Baird’s reduction in target price.

    By Amit Singh
  • uploads///Part
    Healthcare

    Moat Index: Dramatic Sector Allocation Shift in 2018

    The healthcare sector dominated the sector weighting for the Morningstar Wide Moat Index in 2018. The sector returned ~5% in 2018.

    By VanEck
  • uploads///WBA Sales
    Consumer

    Will Walgreens’s Strategic Initiatives Boost Its Sales?

    Walgreens Boots Alliance’s (WBA) sales rose 9.9% to $33.8 billion in the first quarter of fiscal 2019 (which ended on November 30, 2018).

    By Sirisha Bhogaraju
  • uploads///close up _
    Consumer

    How Is Walgreens Boots Alliance Positioned in 2019?

    As of January 18, Walgreens Boots Alliance (WBA) stock has risen 6.0% since the start of 2019.

    By Sirisha Bhogaraju
  • uploads///medicine _
    Consumer

    Why Walgreens Stock Fell despite Beating Estimates

    Walgreens Boots Alliance (WBA) posted better-than-expected first-quarter results on Thursday, December 20.

    By Amit Singh
  • uploads///visa _
    Company & Industry Overviews

    Apple Pay Transactions Rose Significantly in Q4 of Fiscal 2018

    Apple’s (AAPL) Services segment revenue rose 17% YoY to almost $10 billion in the fourth quarter of fiscal 2018.

    By Adam Rogers
  • uploads///CVS ANR
    Consumer

    CVS: Analysts’ Ratings and Target Prices

    CVS Health posted stronger-than-expected third-quarter results on November 6. A few analysts raised the target prices on CVS stock.

    By Amit Singh
  • uploads///CVS Sales
    Consumer

    CVS’s Q3 Sales Beat the Estimate

    CVS Health (CVS) reported stronger-than-expected third-quarter sales. The company reported net sales of $47.3 billion.

    By Amit Singh
  • uploads///pills _
    Consumer

    CVS Stock Rose 5.7% Due to Strong Third-Quarter Results

    CVS reported better-than-expected third-quarter results on November 6. The company’s top and bottom line exceeded analysts’ estimates.

    By Amit Singh
  • uploads///
    Consumer

    How Investors Reacted to Walgreens’s Fourth-Quarter Results

    Walgreens stock has fallen 2.4% YTD (year-to-date). It fell ~10% after Amazon announced the acquisition of Pillpack in June.

    By Sonya Bells
  • uploads///pill _
    Healthcare

    CVS Gets Department of Justice Approval for Aetna Deal

    On October 10, the US Department of Justice gave preliminary approval to the $69 billion deal between CVS Health (CVS) and Aetna (AET).

    By Sonya Bells
  • uploads///family __
    Earnings Report

    Analyst Ratings for UnitedHealth before Q3 2018 Earnings

    Of the 24 analysts covering UNH stock, ten have recommended a “strong buy,” and 13 have recommended a “buy.”

    By Sarah Collins
  • uploads///Comcast residential video customer net additions
    Company & Industry Overviews

    Comcast Is Selling Bonds to Fund the Sky Acquisition

    As of October 2, Comcast (CMCSA) has sold unsecured bonds worth $27 billion to finance its $38.8 billion purchase of 61% of Sky.

    By Sophia Nicholson
  • uploads///close up _
    Consumer

    Walgreens Stock Rises as RBC Increases Price Target 20%

    RBC Capital Markets raised the price target for Walgreens Boots Alliance (WBA) from $68 to $82 (or ~20%) on Monday, October 8.

    By Sonya Bells
  • uploads///
    Consumer

    Walgreens’s EPS to Rise 11% in Q4 2018

    Wall Street expects a 10.7% year-over-year jump in Walgreens Boots Alliance’s (WBA) EPS to $1.45 during the fourth quarter of fiscal 2018.

    By Sonya Bells
  • uploads///
    Consumer

    Rite Aid Reports in-Line EPS in the Second Quarter

    Rite Aid (RAD) reported a second-quarter adjusted net loss from continuing operations of $7.9 million or $0.01 loss per share.

    By Sonya Bells
  • uploads///
    Consumer

    Rite Aid Finally Posts Top-Line Growth in the Second Quarter

    Rite Aid (RAD) reported results for the second quarter—which ended on September 1—yesterday. The company’s top line from continuing operations improved 1.4 % YoY (year-over-year) to $5.42 billion.

    By Sonya Bells
  • uploads///
    Consumer

    After Two Failed Mergers, Where Does Rite Aid Stand Now?

    Struggling with the company’s financial position, Rite Aid’s management has tried to sell the company’s assets since 2015.

    By Sonya Bells
  • uploads///Chart
    Company & Industry Overviews

    Estimates and Recommendations for DaVita on September 17

    Analysts estimate that DaVita (DVA) will report a 25.3% decline in revenues to $11.6 billion in 2018 compared to $15.5 billion in 2017.

    By Mike Benson
  • uploads///
    Consumer

    Strong Q2 2018 Results Cushion CVS Health’s Falling Share Price

    CVS Health’s (CVS) better-than-expected second-quarter results managed to please investors.

    By Sonya Bells
  • uploads///
    Consumer

    CVS Health’s Analyst Ratings Have Improved in 2018

    CVS was upgraded by Citigroup from “neutral” to “buy” on July 9.

    By Sonya Bells
  • uploads///Chart
    Earnings Report

    Novartis’s Q2 2018 Earnings: Sandoz

    Sandoz, the generics arm of Novartis (NVS), reported nearly flat revenues at ~$2.46 billion during Q2 2018.

    By Mike Benson
  • uploads///us pharmacies
    Company & Industry Overviews

    How Pharmacies and Drugstores Are Defending against Amazon

    Amazon’s (AMZN) purchase of PillPack is expected to pose a threat to existing players in the pharmaceutical space.

    By Anne Shields
  • uploads///
    Consumer

    Here’s Why Walgreens Stock Crashed despite Strong Q3 Results

    After Walgreens announced its fiscal Q3 results, Amazon announced its plan to acquire PillPack, an online pharmacy company, and WBA stock crashed.

    By Sonya Bells
  • uploads///
    Consumer

    Walgreens Reports 14% Sales Growth in Fiscal Third Quarter

    Walgreens’s fiscal third-quarter top line increased 14% YoY to $34.3 billion. On a constant currency basis, sales rose 11.8% YoY.

    By Sonya Bells
  • uploads///
    Consumer

    Rite Aid’s Fiscal Q1 2019 Beat Drives Its Stock After Hours

    Rite Aid’s (RAD) better-than-expected results drove its stock by 1.5% in the post-trading session on June 27.

    By Sonya Bells
  • uploads///
    Consumer

    Discussing Rite Aid’s Fiscal Q1 2019 Margins

    Rite Aid (RAD) reported adjusted net income from continuing operations of -$11.5 million, or -$0.01 per share, in the fiscal first quarter of 2019.

    By Sonya Bells
  • uploads///Picture
    Consumer

    Analysts Aren’t So Sure about Rite Aid Stock

    After a disastrous 2017, Rite Aid stock has managed to stay in the green so far this year.

    By Sonya Bells
  • uploads///
    Consumer

    What’s behind Rite Aid’s Deteriorating Margins?

    Rite Aid has witnessed a continuous deterioration in its profitability over the years.

    By Sonya Bells
  • uploads///aid _
    Company & Industry Overviews

    CVS Health Launches Prescription Delivery Service, Stock Jumps ~5%

    Today, CVS Health, the leading pharmacy benefit managers, is up ~5% after announcing the launch of its drug delivery service from all of its US locations.

    By Sarah Collins
  • uploads///dECLINES
    Company & Industry Overviews

    S&P 500’s Top Losses: Why Biogen Declined

    Biogen, which is an American multinational biotechnology company, was the S&P 500’s top loss on June 18.

    By Val Kensington
  • uploads///people _
    Financials

    Why Envision Healthcare Stock Rose ~2.4% Last Week

    Healthcare service provider Envision Healthcare (EVHC) announced its agreement to be acquired by KKR (KKR) last week.

    By Mike Benson
  • uploads///cons non cycl
    Consumer

    What’s the Dividend Yield of the Consumer Non-Cyclical Sector?

    The consumer non-cyclical segment recorded a dividend yield of 3%.

    By Amanda Lawrence
  • uploads///
    Miscellaneous

    Analysts’ Take on CVS Health and Walgreens

    Walgreens Boots Alliance and CVS Health are both well-covered stocks. While Walgreens is tracked by 27 analysts, 25 analysts cover CVS.

    By Sonya Bells
  • uploads///
    Company & Industry Overviews

    CVS Health and Walgreens: Financial Health

    CVS recorded total sales of $186 billion (+4% YoY) in the last 12 months. The Pharmacy Services segment was the company’s biggest moneymaker.

    By Sonya Bells
  • uploads///pills medical money
    Company & Industry Overviews

    CVS Health versus Walgreens: Comparing Pharmacy Giants

    Around 70% of the US population lives within three miles of a CVS store, while more than 75% of the population lives within five miles of a Walgreens store.

    By Sonya Bells
  • uploads///trump tower _
    Consumer

    Drugstore Stocks Tumble ahead of Trump’s New Drug Policy

    The stocks of top drugstore chains CVS Health (CVS) and Walgreens Boots Alliance (WBA) were down yesterday amid ongoing tensions regarding a policy change in US drug pricing.

    By Sonya Bells
  • uploads///
    Earnings Report

    A Quick Overview of CVS Health’s 1Q18 Profitability

    While CVS Health (CVS) fumbled with its 1Q18 top-line expectations, it still managed to cruise ahead of Wall Street’s bottom-line forecasts.

    By Sonya Bells
  • uploads///recommendation
    Earnings Report

    Recommendations for UNH Stock after Its 1Q18 Results: All ‘Buy’

    Of the 22 analysts tracking UNH stock on April 19, 50% rated it as a “strong buy,” and the remaining 50% of these analysts rated the company as a “buy.”

    By Sarah Collins
  • uploads///
    Consumer

    Rite Aid’s Top Line Fell for 4th Straight Quarter in Fiscal 4Q18

    Rite Aid’s (RAD) top line for fiscal 4Q18 fell 8.6% YoY to $5.4 billion, missing the average consensus expectation by $180 million.

    By Sonya Bells
  • uploads///BUSINESS POSITIONING
    Earnings Report

    How Is UNH’s Optum Business Positioned in the Industry?

    UnitedHealth Group is, by revenue, the largest healthcare company in the world.

    By Sarah Collins
  • uploads///family _
    Earnings Report

    Analysts’ Recommendations for UnitedHealth Group

    UnitedHealth Group is the world’s largest healthcare company in terms of revenue. In fiscal 2017, it generated revenue of $201 billion.

    By Sarah Collins
  • uploads///image
    Fund Managers

    Why Goldman Sachs Has Positive Views on CVS Health

    Goldman Sachs (GS) also included CVS Health (CVS) in its domestic stock pick list.

    By Sarah Sands
  • uploads///gainers
    Company & Industry Overviews

    Top Gainers in the Consumer Sector Last Week

    Florida-based Lennar (LEN) released its fiscal 1Q18 results on April 4, 2018.

    By Sushree Mohanty
  • uploads///R
    Consumer

    How Wall Street Views Rite Aid Stock ahead of 4Q18 Results

    Rite Aid’s stock has plunged around 18% this year after falling 76% last year.

    By Sonya Bells
  • uploads///medicine _
    Company & Industry Overviews

    Walmart Eyes Growth Avenues—Healthcare Could Be One

    CNBC has reported that Walmart is looking to acquire PillPack, an online pharmacy startup, for less than $1 billion.

    By Amit Singh
  • uploads///
    Consumer

    No Recommendation Changes after Walgreens Releases 2Q18 Results

    Walgreens Boots Alliance (WBA) stock rose 3.1% after it reported better-than-expected results on March 28, 2018.

    By Sonya Bells
  • uploads///
    Consumer

    Could Walgreens Exceed Expectations Again in 2Q18?

    Wall Street has projected a strong quarter for Walgreens Boots Alliance (WBA) in 2Q18, projecting a 14% YoY (year-over-year) increase in its EPS (earnings per share).

    By Sonya Bells
  • uploads///grocery store _
    Consumer

    SuperValu Has Decided to Sell Farm Fresh

    SuperValu (SVU) announced on March 14 that it’s selling 21 of its 38 Farm Fresh stores to three grocery store chains.

    By Sonya Bells
  • uploads///LHC
    Company & Industry Overviews

    What’s LHC Group’s Business Strategy?

    In 2018, LHC Group is expected to report revenue of $1.2 billion. What about its peers?

    By Kenneth Smith
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.